These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 21515025)

  • 1. [Comparison of platelet monitoring in patients receiving thromboprophylaxis with fondaparinux or a low molecular weight heparin. The Ariane study].
    Gouin-Thibault I; Liard F; Van-Ganse E; Vespa L; Gaudin AF; Nachit-Ouinekh F
    Presse Med; 2011 Sep; 40(9 Pt 1):e365-75. PubMed ID: 21515025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux or low molecular weight heparin in a large cohort of consecutive patients undergoing major orthopaedic surgery - findings from the ORTHO-TEP registry.
    Donath L; Lützner J; Werth S; Kuhlisch E; Hartmann A; Günther KP; Weiss N; Beyer-Westendorf J
    Br J Clin Pharmacol; 2012 Dec; 74(6):947-58. PubMed ID: 22515679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Geerts WH; Bergqvist D; Pineo GF; Heit JA; Samama CM; Lassen MR; Colwell CW
    Chest; 2008 Jun; 133(6 Suppl):381S-453S. PubMed ID: 18574271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Geerts WH; Pineo GF; Heit JA; Bergqvist D; Lassen MR; Colwell CW; Ray JG
    Chest; 2004 Sep; 126(3 Suppl):338S-400S. PubMed ID: 15383478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
    Kahn SR; Lim W; Dunn AS; Cushman M; Dentali F; Akl EA; Cook DJ; Balekian AA; Klein RC; Le H; Schulman S; Murad MH
    Chest; 2012 Feb; 141(2 Suppl):e195S-e226S. PubMed ID: 22315261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of venous thromboembolic events by fondaparinux 2.5mg in patients hospitalized for an acute medical illness. ArchiMed Study].
    Leroyer C; Mahé I; Daurès JP; Quéré I; Aubin C; Compagnon A; Doussaint J; Schück S; Pouchain D
    J Mal Vasc; 2015 Jul; 40(4):248-58. PubMed ID: 26051860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of venous thromboembolism in hospitalized acutely ill medical patients: focus on the clinical utility of (low-dose) fondaparinux.
    Di Nisio M; Porreca E
    Drug Des Devel Ther; 2013; 7():973-80. PubMed ID: 24068866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fondaparinux as alternative anticoagulant to warfarin or low-molecular-weight heparin for recurrent venous thrombosis.
    Thachil J
    Ann Pharmacother; 2014 Mar; 48(3):420-4. PubMed ID: 24473488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing venous thromboembolism in hospitalized patients with cancer: improving compliance with clinical practice guidelines.
    Brown A
    Am J Health Syst Pharm; 2012 Mar; 69(6):469-81. PubMed ID: 22382477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
    van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
    Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylaxis of venous thromboembolism: low molecular weight heparin compared to the selective anticoagulants rivaroxaban, dabigatran and fondaparinux.
    Welzel D; Hull R; Fareed J
    Int Angiol; 2011 Jun; 30(3):199-211. PubMed ID: 21617603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fondaparinux Sodium Compared With Low-Molecular-Weight Heparins for Perioperative Surgical Thromboprophylaxis: A Systematic Review and Meta-analysis.
    Kumar A; Talwar A; Farley JF; Muzumdar J; Schommer JC; Balkrishnan R; Wu W
    J Am Heart Assoc; 2019 May; 8(10):e012184. PubMed ID: 31070069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
    Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VTE prophylaxis for the medical patient: where do we stand? - a focus on cancer patients.
    Cohen AT; Nandini B; Wills JO; Ota S
    Thromb Res; 2010 Apr; 125 Suppl 2():S21-9. PubMed ID: 20434000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adherence to guidelines for the treatment of venous thromboembolism in cancer patients: a retrospective analysis of 145 cases].
    Belhadj Chaidi R; Thollot C; Ferru A; Roblot P; Landron C
    J Mal Vasc; 2013 May; 38(3):185-92. PubMed ID: 23619202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Economic consequences of biological monitoring and medical complications of injectable anticoagulants in France].
    Paubel P; Cousin M; Amar C; Gourmelen J; Fabron C; Detournay B
    J Mal Vasc; 2016 Dec; 41(6):371-377. PubMed ID: 27817998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and diagnosis of heparin-induced thrombocytopenia (HIT) in patients with traumatic injuries treated with unfractioned or low-molecular-weight heparin: a literature review.
    Bloemen A; Testroote MJ; Janssen-Heijnen ML; Janzing HM
    Injury; 2012 May; 43(5):548-52. PubMed ID: 21640991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choosing the right heparin prophylaxis strategy in medical patients at risk for developing VTE: an evidence-based approach.
    Harrington DW
    Hosp Pract (1995); 2010 Nov; 38(4):18-28. PubMed ID: 21068523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of fondaparinux with low molecular weight heparin for venous thromboembolism prevention in patients requiring rigid or semi-rigid immobilization for isolated non-surgical below-knee injury.
    Samama CM; Lecoules N; Kierzek G; Claessens YE; Riou B; Rosencher N; Mismetti P; Sautet A; Barrellier MT; Apartsin K; Jonas M; Caeiro JR; van der Veen AH; Roy PM;
    J Thromb Haemost; 2013 Oct; 11(10):1833-43. PubMed ID: 23965181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.